Stock Research for ACHN

ACHN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ACHN Stock Chart & Research Data

The ACHN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACHN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACHN Due diligence Resources & Stock Charts

The ACHN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACHN Detailed Price Forecast - CNN Money CNN View ACHN Detailed Summary - Google Finance
Yahoo View ACHN Detailed Summary - Yahoo! Finance Zacks View ACHN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ACHN Trends & Analysis - Trade-Ideas Barrons View ACHN Major Holders - Barrons
NASDAQ View ACHN Call Transcripts - NASDAQ Seeking View ACHN Breaking News & Analysis - Seeking Alpha
Spotlight View ACHN Annual Report - CompanySpotlight.com OTC Report View ACHN OTC Short Report - OTCShortReport.com
TradeKing View ACHN Fundamentals - TradeKing Charts View ACHN SEC Filings - Bar Chart
WSJ View Historical Prices for ACHN - The WSJ Morningstar View Performance/Total Return for ACHN - Morningstar
MarketWatch View the Analyst Estimates for ACHN - MarketWatch CNBC View the Earnings History for ACHN - CNBC
StockMarketWatch View the ACHN Earnings - StockMarketWatch MacroAxis View ACHN Buy or Sell Recommendations - MacroAxis
Bullish View the ACHN Bullish Patterns - American Bulls Short Pains View ACHN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ACHN Stock Mentions - StockTwits PennyStocks View ACHN Stock Mentions - PennyStockTweets
Twitter View ACHN Stock Mentions - Twitter Invest Hub View ACHN Investment Forum News - Investor Hub
Yahoo View ACHN Stock Mentions - Yahoo! Message Board Seeking Alpha View ACHN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ACHN - SECform4.com Insider Cow View Insider Transactions for ACHN - Insider Cow
CNBC View ACHN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACHN - OTC Markets
Yahoo View Insider Transactions for ACHN - Yahoo! Finance NASDAQ View Institutional Holdings for ACHN - NASDAQ


Stock Charts

FinViz View ACHN Stock Insight & Charts - FinViz.com StockCharts View ACHN Investment Charts - StockCharts.com
BarChart View ACHN Stock Overview & Charts - BarChart Trading View View ACHN User Generated Charts - Trading View




Latest Financial News for ACHN


Research Report Identifies The Goodyear Tire & Rubber, Prudential Financial, PennyMac Mortgage Investment Trust, Achillion Pharmaceuticals, American Software, and Lantheus with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Tuesday February 12, 2019

NEW YORK, Feb. 12, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.


Achillion Appoints Brian Di Donato as Chief Financial Officer
Posted on Monday February 11, 2019

Achillion Pharmaceuticals, Inc. (ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced the appointment of Brian Di Donato to the position of Senior Vice President and Chief Financial Officer, effective immediately. Mr. Di Donato has over 20 years of financial and leadership experience and will assume responsibility for finance, accounting and treasury as well as continue to lead investor relations. “Brian joined the Achillion team in August 2018 and has already made significant contributions alongside the new management team as we accelerate our clinical programs and prepare for registrational trials,” commented Joseph Truitt, President and Chief Executive Officer of Achillion.


Alexion's (ALXN) Earnings Beat Estimates in Q4, Shares Up
Posted on Monday February 04, 2019

Alexion (ALXN) exceeds earnings and sales estimates in the fourth quarter of 2018 on strong performance by Soliris.


Achillion Announces First Dosing in Phase 1 Multiple Ascending Dose Study of ACH-5228 Next-Generation Oral Factor D Inhibitor in Healthy Volunteers
Posted on Thursday January 31, 2019

- ACH-5228, with improved potency and half-life, increases alternative pathway inhibition -- Achillion planning Investigational New Drug (IND) submission in fourth quarter of.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.